Approval · Notice of Compliance 10007 · 2009
STEMGEN: Notice of Compliance 10007
Issued January 26, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10007
- Date
- January 26, 2009
- Company
- Biovitrum Ab (Publ)Stockholm, Saone Et Loire, Sweden
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Hematopoietic agent